Fat embolism syndrome: a review of the pathophysiology and physiological basis of treatment.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D001778:Blood Coagulation Disorders / Q000209:etiology / Q000378:metabolism; D004620:Embolism, Fat / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D050723:Fractures, Bone / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008168:Lung / Q000503:physiopathology; D012157:Mononuclear Phagocyte System / Q000503:physiopathology; D009895:Opsonin Proteins; D010587:Phagocytosis; D014280:Triglycerides / Q000378:metabolism; D014947:Wounds and Injuries / Q000150:complications / Q000378:metabolism / Q000503:physiopathology
D000305:Adrenal Cortex Hormones; D005230:Fatty Acids, Nonesterified; D008079:Lipoproteins, VLDL; D009895:Opsonin Proteins; D014280:Triglycerides